Anticancer Research: 46 (3)

March 2026; Volume 46,Issue 3

Review

Open Access
Primary Debulking Surgery Versus Interval Debulking Surgery in the Management of Advanced-Stage Ovarian Cancer
JOHN P. MICHA, RANDY D. BOHART, JOSHUA P. GORMAN and BRAM H. GOLDSTEIN

Anticancer Research March 2026, 46 (3) 1175-1182; DOI: https://doi.org/10.21873/anticanres.18021

Experimental Studies

Open Access
Cytostatic Benzylidene-isophthaloylhydazides With Diminished Neurotoxicity
MOHAMMAD HOSSAIN, ROSS A. FILBRUN, SHAYNE M. ROTH, HIROSHI SAKAGAMI, SHIGERU AMANO, HARUNA NAGASE, KEITARO SATOH and JONATHAN R. DIMMOCK

Anticancer Research March 2026, 46 (3) 1183-1195; DOI: https://doi.org/10.21873/anticanres.18022
Open Access
Iodine-Hoechst Enhances X-ray Sensitivity of Cancer Cells Under Normal and Low Oxygen Conditions
YUYA HIGASHI, MOMOKA GODA, SAYA KOBAYASHI, YUSEI SHINOHARA, AOI KOMATSU, MASAHIDE TOMINAGA, HIROSHI HARADA, FUYUHIKO TAMANOI, YOSHIHIRO UTO and KOTARO MATSUMOTO

Anticancer Research March 2026, 46 (3) 1197-1211; DOI: https://doi.org/10.21873/anticanres.18023
Open Access
SLFN11 Drives GM-CSF–mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma
YOHEI OKUDA, JUNKO MURAI, TSUYOSHI TAKASHIMA, NAOYA SAKAMOTO, AKIHIRO YOSHIMURA, MASARU TANI, YUKI HORIBE, YUTONG LIU, NESRINE SASSI, TOSHIKI OKA, TOSHIHIRO UEMURA, AKINARU YAMAMOTO, GAKU YAMAMICHI, YU ISHIZUYA, TAKUJI HAYASHI, YOSHIYUKI YAMAMOTO, KOJI HATANO, ATSUNARI KAWASHIMA, EIICHI MORII, NORIO NONOMURA and TAIGO KATO

Anticancer Research March 2026, 46 (3) 1213-1234; DOI: https://doi.org/10.21873/anticanres.18024
Open Access
Exploring the Contribution of Interleukin-17 Genetic Polymorphisms to Pterygium Risk
HUNG-CHIH CHEN, NING-YI HSIA, PEI-SHIN HU, TE-CHUN HSIA, YA-CHEN YANG, WEN-SHIN CHANG, SHIH-CHUN CHAO, DA-TIAN BAU and CHIA-WEN TSAI

Anticancer Research March 2026, 46 (3) 1235-1245; DOI: https://doi.org/10.21873/anticanres.18025
Open Access
Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells
SEIICHI OKABE, SEIICHIRO YOSHIZAWA, KAI OSONE, YUYA ARAI, MITSURU MORIYAMA and DAIGO AKAHANE

Anticancer Research March 2026, 46 (3) 1247-1257; DOI: https://doi.org/10.21873/anticanres.18026
You have access
EZH2 Expression Is Associated With Sensitivity to Inhibitors and Promotes Malignancy in Endometrial Cancer Cells
TAKAFUMI ONISHI, HIROYA NIIMI, AYA KUMAZAKI, YUTO MASAKI, SHOMA NOMURA, HIROKAZU ODASHIMA, YUKIHIKO OSAWA and MANABU HATTORI

Anticancer Research March 2026, 46 (3) 1259-1269; DOI: https://doi.org/10.21873/anticanres.18027
You have access
Immunohistological Expression of Sclerostin in Metastatic Osteolytic Bone Tumors
KAZUHIKO HASHIMOTO, SHUNJI NISHIMRUA, HIROKI TAN, TOMOHIKO ITO and KOJI GOTO

Anticancer Research March 2026, 46 (3) 1271-1279; DOI: https://doi.org/10.21873/anticanres.18028
You have access
Exploring SLC1A5 (ASCT2), SLC7A5, and SLC3A2 (LAT1) Genetic Variants in Colorectal Cancer: Implications for Prognosis and Personalized Care
CATARINA LOPES, CATARINA MACEDO-SILVA, MÓNICA FARINHA, JOÃO COSTA, SOFIA PINELAS, ISABEL VILAS-BOAS, MÁRIO DINIS-RIBEIRO, CARINA PEREIRA and RUI MEDEIROS

Anticancer Research March 2026, 46 (3) 1281-1292; DOI: https://doi.org/10.21873/anticanres.18029
You have access
CD133⁺ Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense
NAN-NAN YU, YUE LIU, XIAO-YU GUO, KEE KWANG KIM, JI HYE KIM, TAEHO KWON, DONG HUN LEE and HU-NAN SUN

Anticancer Research March 2026, 46 (3) 1293-1306; DOI: https://doi.org/10.21873/anticanres.18030
You have access
Repetitive Magnetic Stimulation Modulates the Gene Expression of Neurotrophins and their Receptors in Neuroblastoma Cells
AMANDA STIEVEN, DIRSON JOÃO STEIN, KHETRÜIN JORDANA FIUZA, PAULO ROBERTO STEFANI SANCHES, LICIANE FERNANDES MEDEIROS, FELIPE FREGNI, WOLNEI CAUMO, MARIANE DA CUNHA JAEGER and IRACI L.S. TORRES

Anticancer Research March 2026, 46 (3) 1307-1321; DOI: https://doi.org/10.21873/anticanres.18031
You have access
Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure
ESHAT F. HAQUE, RYOSUKE TANINO, TAMIO OKIMOTO, TAKAMASA HOTTA, TAKAE OKUNO, KENTO KONO, YUKARI TSUBATA and TAKESHI ISOBE

Anticancer Research March 2026, 46 (3) 1323-1335; DOI: https://doi.org/10.21873/anticanres.18032
You have access
Over-expression of Paternally Expressed Gene 10 (PEG10) Is Associated With Poor Prognosis in Upper Tract Urothelial Carcinomas
MAI OKAZAKI, YOHEI SEKINO, TETSUTARO HAYASHI, GO KOBAYASHI, HIKARU NAKAHARA, RYO TASAKA, YUKI KOHADA, KENSHIRO TAKEMOTO, MIKI NAITO, SHUNSUKE MIYAMOTO, KOHEI KOBATAKE, HIROYUKI KITANO, KEISUKE GOTO, AKIHIRO GORIKI, KEISUKE HIEDA, HIROAKI NIITSU, TAKAO HINOI and NOBUYUKI HINATA

Anticancer Research March 2026, 46 (3) 1337-1348; DOI: https://doi.org/10.21873/anticanres.18033
You have access
Erlotinib Induces Cell Death by Blocking NIX-mediated Mitophagy Through Lysosomal Swelling in IDH1-mutant Cholangiocarcinoma
YONGHYUN KANG, CHORONG KIM, CHAN YEOP JEONG, DA SOL LEE, CHANGHOON YOO, INKEUN PARK, SEONMIN LEE and KYU-PYO KIM

Anticancer Research March 2026, 46 (3) 1349-1364; DOI: https://doi.org/10.21873/anticanres.18034
You have access
Mechanistic Studies of Anticancer Effects of Salicylaldehyde Benzoylhydrazone in 2D/3D Lung Cancer Cell Cultures
WANNAPA SANGSEEKEW, JUTATIP BOONSOMBAT, SANIT THONGNEST, JITNAPA SIRIRAK, THIWAREE SORNPRACHUM, KRIENGSAK LIRDPRAPAMONGKOL, JISNUSON SVASTI, SOMSAK RUCHIRAWAT and SIRIPORN KEERATICHAMROEN

Anticancer Research March 2026, 46 (3) 1365-1387; DOI: https://doi.org/10.21873/anticanres.18035
You have access
Dual Role of PSMB9 Linking Immune Activation and Tumor Adaptation in Hepatocellular Carcinoma With Therapeutic and Prognostic Implications
YITING LIU, JIAOJIAO CAO, HAIYANG YU, QICHEN SUN, TIANYI ZHU, YU ZHOU, XIAOYI DING, JIAN WANG, XIAOXIA GUO and ZHIYUAN WU

Anticancer Research March 2026, 46 (3) 1389-1410; DOI: https://doi.org/10.21873/anticanres.18036
You have access
Immunohistochemical Expression and Clinicopathological Assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 Expression in Desmoid Tumor
KAZUHIKO HASHIMOTO, SHUNJI NISHIMURA, HIROKI TAN, TOMOHIKO ITO and KOJI GOTO

Anticancer Research March 2026, 46 (3) 1411-1419; DOI: https://doi.org/10.21873/anticanres.18037
You have access
FAS/FAS-ligand Apoptotic Complex Deregulation in Laryngeal Squamous Cell Carcinomas
MICHAIL ATHANASOPOULOS, VASILEIOS PAPANIKOLAOU, DIMITRIOS ROUKAS, ARISTEIDIS CHRYSOVERGIS, GEORGIOS PAPANASTASIOU, MARIA ADAMOPOULOU, IOANNA E. METAXAS, EVANGELOS TSIAMBAS, GEORGIOS TSOUVELAS, NICHOLAS MASTRONIKOLIS, EYTHIMIOS KYRODIMOS, NIKOLAOS KAVANTZAS and GEORGIOS AGROGIANNIS

Anticancer Research March 2026, 46 (3) 1421-1428; DOI: https://doi.org/10.21873/anticanres.18038
You have access
Gallic Acid as a Non-cytotoxic Modulator of the ROS–EGFR–ERK–EMT Axis in Xenograft-derived T98G Glioblastoma Cells
YU-FENG SU, HUEY-JIUN KO, WEI-CHUNG CHEN, FU-LONG HUANG, JOON-KHIM LOH and CHENG-YU TSAI

Anticancer Research March 2026, 46 (3) 1429-1447; DOI: https://doi.org/10.21873/anticanres.18039
You have access
Adenosine Inhibits Cholangiocarcinoma by a Concurrent Activation of AMPK and mTORC1 Signaling Pathways
JOMNARONG LERTSUWAN, JISNUSON SVASTI and JUTAMAAD SATAYAVIVAD

Anticancer Research March 2026, 46 (3) 1449-1460; DOI: https://doi.org/10.21873/anticanres.18040
You have access
Synergistic Anticancer Effects of the PLK1 Inhibitor BI-2536 and β-Glucan in Colon and Gastric Cancer Cells
RABIA GÖKÇE TAKCI, BÜLENT SARAÇ, LEVENT HACISÜLEYMAN, BURCU ŞAHİNBAŞ and ZIAD JOHA

Anticancer Research March 2026, 46 (3) 1461-1474; DOI: https://doi.org/10.21873/anticanres.18041
You have access
The Privileged Scaffold Quinoline in Derivatives With Anticancer Potential Mediated by Late Apoptosis
DENISE DIEDRICH, ELENILSON F. SILVA, JULIA B. WILLIG, THAÍS C. RUARO, NÁDIA M.G. COUTO, MICKAEL JEAN, GLORIA N.S. SILVA, DIOGO A. PILGER, ALINE R. ZIMMER, PIERRE V. WEGUE and SIMONE C.B. GNOATTO

Anticancer Research March 2026, 46 (3) 1475-1487; DOI: https://doi.org/10.21873/anticanres.18042

Clinical Studies

Open Access
Risk of Non-colorectal Malignancies in Sporadic Versus Lynch Syndrome–associated dMMR Colorectal Cancer
IOANNIS GKEKAS, JAN NOVOTNY, TUOMAS KAPRIO, PAVEL FABIAN, CAMILLA BÖCKELMAN, SOFIA EDIN, KARIN STRIGÅRD, TOMAS SVOBODA, JAANA HAGSTRÖM, CAJ HAGLUND and RICHARD PALMQVIST

Anticancer Research March 2026, 46 (3) 1489-1496; DOI: https://doi.org/10.21873/anticanres.18043
Open Access
Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study
NAOYA TONOMURA, KENSUKE YOSHIDA, HAJIME MORITA, MASAKI NAKAI, YUSUKE KAWAMURA, TAKUMA MATSUMOTO, YOSHINOBU GOHARA, NAOTO HOSHINO, MANAMI BANBA, AYAKO YAMAGUCHI, MASAKI TACHIBANA, TOMOKI FUKUSHIMA, HIROKI HOSOKAWA, TAKUYA MURA, TSUYOSHI YABUKI, SHINICHI WATANABE and MUNETOSHI SUGIURA

Anticancer Research March 2026, 46 (3) 1497-1506; DOI: https://doi.org/10.21873/anticanres.18044
You have access
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Outcomes for Colorectal and Mesothelioma Peritoneal Metastases: A 12-year Study
HARLEEN KAUR, GERSHWIN ISAAC SINGH BHALL, CHRISTOPHER LAUDER, NIGEL DA SILVA, TIMOTHY PRICE, MARKUS TROCHSLER, JOSEPHINE WRIGHT, SUSAN LESLEY WOODS and PETER HEWETT

Anticancer Research March 2026, 46 (3) 1507-1515; DOI: https://doi.org/10.21873/anticanres.18045
You have access
Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis
SAMULI SALMINEN, LAURA TUOMIKOSKI, MAIJA TARKKANEN, TOM WIKLUND, MIKKO TENHUNEN, RIIKKA NEVALA and MIKA SAMPO

Anticancer Research March 2026, 46 (3) 1517-1522; DOI: https://doi.org/10.21873/anticanres.18046
You have access
Tolerance and Outcomes of Partial Breast Radiation in a Community-based Setting
ANDREW WONG, ALEXIS RAFAEL NARVAEZ-ROJAS, WILLIAM DIEHL, DIANA ADDIS, WINNIE POLEN, PRIYA JADEJA, ALISON PRICE and DAVID SCHREIBER

Anticancer Research March 2026, 46 (3) 1523-1528; DOI: https://doi.org/10.21873/anticanres.18047
Open Access
Roles of GPX4 and FSP1 in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy
TOMOHIRO TAKAHASHI, YUJI SHISHIDO, TOMOHIKO SAKABE, JUNPEI ORIHARA, SHOTA SHIMIZU, KOZO MIYATANI, TOMOYUKI MATSUNAGA, TERUHISA SAKAMOTO, YOSHIHISA UMEKITA and YOSHIYUKI FUJIWARA

Anticancer Research March 2026, 46 (3) 1529-1543; DOI: https://doi.org/10.21873/anticanres.18048
You have access
Clinical Utility of Tremelimumab/Durvalumab as First-line Treatment for Unresectable Hepatocellular Carcinoma: Serum Cytokine Profile Insights
KUNIHIDE MOHRI, HIDENARI NAGAI, TAKANORI MUKOZU, TEPPEI MATSUI, HIDEKI NAGUMO, NAOYUKI YOSHIMINE, KOJIRO KOBAYASHI, YU OGINO, NORITAKA WAKUI, KOICHI MOMIYAMA, KOJI HIGAI, TAKAHISA MATSUDA and YOSHINORI IGARASHI

Anticancer Research March 2026, 46 (3) 1545-1556; DOI: https://doi.org/10.21873/anticanres.18049
You have access
Plan Quality Variability in Radiotherapy of Whole Breast and Regional Lymph Nodes: An Intra-institutional Analysis
GRACINDA JOHANSSON and ARIADNI KYRIAKOGIANNAKI

Anticancer Research March 2026, 46 (3) 1557-1568; DOI: https://doi.org/10.21873/anticanres.18050
You have access
Autologous Tumor Vaccination in Melanoma and Colon Cancer Patients With Recurrent Liver Metastases: A Case Series
OFRA MAIMON, BENJAMIN NISMAN, INNA BEN-DAVID, ANNA KUZNETZ, YAEL GELFAND, MICHAL LOTEM, ARON POPOVTZER, NADA SALAYMEH, SALOME KHUTSURAULI and TAMAR PERETZ

Anticancer Research March 2026, 46 (3) 1569-1575; DOI: https://doi.org/10.21873/anticanres.18051
You have access
Expression of YME1 Like 1 ATPase Increases With the Stage of Adrenocortical Carcinoma Tissue and Is Associated With Poor Patient Prognosis
SHIN-NOSUKE YAMASHITA, YOSHIATSU TANAKA, SHAJEDUL ISLAM, TAKAO KITAGAWA, KAZUHIRO TOKUDA, DURGA PAUDEL, SARITA GIRI, TOHRU OHTA, FUMIYA HARADA, HIROKI NAGAYASU and YASUHIRO KURAMITSU

Anticancer Research March 2026, 46 (3) 1577-1582; DOI: https://doi.org/10.21873/anticanres.18052
You have access
Expression of Vascular Endothelial Growth Factor A in Gallbladder Cancer Cells: A Clinicopathological Study
TAKAFUMI OKAYAMA, TAKASHI TANIGUCHI, TAKAHIRO TOMOSUGI, RYUICHIRO KIMURA, ATSUSHI FUJII, YUSUKE WATANABE, NOBORU IDENO, NAOKI IKENAGA, KOHEI NAKATA, TAKEO YAMAMOTO, YOSHINAO ODA and MASAFUMI NAKAMURA

Anticancer Research March 2026, 46 (3) 1583-1589; DOI: https://doi.org/10.21873/anticanres.18053
You have access
Long-term Outcomes and Functional Limitations of Liquid Nitrogen–treated Autografts in Limb Salvage Surgery for Bone Malignancies
MASANORI KAWANO, YUTA KUBOTA, ICHIRO ITONAGA, NOBUHIRO KAKU and KAZUHIRO TANAKA

Anticancer Research March 2026, 46 (3) 1591-1598; DOI: https://doi.org/10.21873/anticanres.18054
Open Access
Overall Survival of Glioblastoma Patients Treated With a Combination of 7 Micronutrients: A Nutraceutical Trial
HARCHARAN KAUR ROOPRAI, PATRICK LAWRENCE, KEYOUMARS ASHKAN, RONALD BEANEY, GEOFFREY J. PILKINGTON and RICHARD W. GULLAN

Anticancer Research March 2026, 46 (3) 1599-1608; DOI: https://doi.org/10.21873/anticanres.18055
You have access
Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab–Bevacizumab
HISANORI MUTO, TEIJI KUZUYA, YOSHIHIKO TACHI, YOSUKE NAGANO, YUTARO KAJINO, MISAE MATSUSHITA, SEIYA HAGIHARA, SATOSHI YAMAMOTO, TAKASHI KOBAYASHI, YOSHIAKI KATANO, NAOKI OHMIYA, SENJU HASHIMOTO, MIZUKI ARIGA, SAYAKA MORISAKI, GAKUSHI KOMURA, TAKUJI NAKANO, HIROYUKI TANAKA, KAZUNORI NAKAOKA, EIZABURO OHNO, KOHEI FUNASAKA, MITSUO NAGASAKA, RYOJI MIYAHARA and YOSHIKI HIROOKA

Anticancer Research March 2026, 46 (3) 1609-1618; DOI: https://doi.org/10.21873/anticanres.18056
You have access
Clinical Significance of LRG1 Protein Expression in Locally Advanced Gastric Cancer After Curative Resection
HAYATO WATANABE, TOMOKO JITSUKATA, YUKIHIKO HIROSHIMA, ITARU HASHIMOTO, NORIHIRO AKIMOTO, YUTA NAKAYAMA, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TAKANOBU YAMADA, TAKASHI OGATA, YOHEI MIYAGI, AYA SAITO and TAKASHI OSHIMA

Anticancer Research March 2026, 46 (3) 1619-1627; DOI: https://doi.org/10.21873/anticanres.18057
You have access
Prediction of Pathological Response and Prognosis After Surgery by Tumor Reduction During Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma
NAO KITASAKI, YOICHI HAMAI, RYOSUKE HIROHATA, MANATO OHSAWA, YUTA IBUKI, TOMOAKI KUROKAWA, MANABU EMI and MORIHITO OKADA

Anticancer Research March 2026, 46 (3) 1629-1638; DOI: https://doi.org/10.21873/anticanres.18058
You have access
Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status
YURI UEDA, TAKURO OKADA, ISAKU OKAMOTO, CHIHIRO FUSHIMI, TAKASHI MATSUKI, HIDEAKI TAKAHASHI, HIROKI SATO, TAKAHITO KONDO, KUNHIKO TOKASHIKI, KENJI HANYU, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, TATSUO MASUBUCHI, YUICHIRO TADA, GO OMURA, TAKU YAMASHITA, NOBUHIKO ORIDATE and KIYOAKI TSUKAHARA

Anticancer Research March 2026, 46 (3) 1639-1650; DOI: https://doi.org/10.21873/anticanres.18059
You have access
Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in Lenvatinib Therapy
MASANARI TSUJI, KAZUO KOBAYASHI, KAZUYOSHI KAWAKAMI, NAOKI FUKUDA, TAKASHI YOKOKAWA, YUTARO MAE, KOKI HASHIMOTO, AZUSA SOEJIMA, SHUNGO IMAI, NAOKO YOSHIDA, SATOKO HORI, NAOKI SASAHIRA, MAYU YUNOKAWA and MASAKAZU YAMAGUCHI

Anticancer Research March 2026, 46 (3) 1651-1659; DOI: https://doi.org/10.21873/anticanres.18060
You have access
Immature Peritumoral Tertiary Lymphoid Structures Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After NAC
MARI NABEYA, MASAO NAKAJIMA, RYOUICHI TSUNEDOMI, TAKAHIRO OZASA, YUTA KIMURA, HIROTO MATSUI, YUKIO TOKUMITSU, YOSHITARO SHINDO, MICHIHISA IIDA, YUKI NAKAGAMI, YOSHINOBU HOSHII, TATSUYA IOKA, HIDENORI TAKAHASHI and HIROAKI NAGANO

Anticancer Research March 2026, 46 (3) 1661-1676; DOI: https://doi.org/10.21873/anticanres.18061
You have access
Prognostic Value of Metabolic Parameters on Dedicated Breast Positron Emission Tomography in Luminal Breast Cancer
AZUSA KAI, SHINSUKE SASADA, AI AMIOKA, HIDEO SHIGEMATSU and MORIHITO OKADA

Anticancer Research March 2026, 46 (3) 1677-1684; DOI: https://doi.org/10.21873/anticanres.18062
You have access
Leptomeningeal Metastasis in Patients With EGFR-positive NSCLC: A Propensity-matched Retrospective Study of Patients With EGFR-negative NSCLC
HIROAKI SATOH, KUNIHIKO MIYAZAKI, RYOTA NAKAMURA, AYUMI WATANABE, YOSUKE MAEZAWA, GEN OHARA, NORIHIRO KIKUCHI and TOSHIHIRO SHIOZAWA

Anticancer Research March 2026, 46 (3) 1685-1695; DOI: https://doi.org/10.21873/anticanres.18063
You have access
Effectiveness of a Physician–Pharmacist Collaborative Protocol for Universal Hepatitis B Virus Screening Prior to Chemotherapy in Cancer Patients
HIROKO KATO-HAYASHI, KENJI IMAI, MASAYUKI ISHIDA, RYO KOBAYASHI, HIROTOSHI IIHARA, HIROYASU SAKAI, KEISUKE KUMADA, MASAHITO SHIMIZU and AKIO SUZUKI

Anticancer Research March 2026, 46 (3) 1697-1705; DOI: https://doi.org/10.21873/anticanres.18064
You have access
A Real-World Evaluation of Health-Related Quality of Life Using the EQ-5D-5L Instrument in Patients Undergoing Radiotherapy for Prostate Cancer
TANJA SPRAVE, SIMON FAUSER, PETROS PAPLOMATAS, HENNING SCHÄFER, SIMON KB SPOHN, ANCA-LIGIA GROSU and RALUCA STOIAN

Anticancer Research March 2026, 46 (3) 1707-1718; DOI: https://doi.org/10.21873/anticanres.18065
You have access
Evaluation of the Validity of Pancreatoduodenectomy for Elderly Patients With Ampullary Carcinoma from the Perspective of Nutritional Status at Recurrence
WATARU IZUMO, RYO SAITO, HIDETAKE AMEMIYA, HIROTO TANAKA, YUDAI HIGUCHI, TAKASHI NAKAYAMA, KAZUNORI TAKAHASHI, SUGURU MARUYAMA, KOICHI TAKIGUCHI, KATSUTOSHI SHODA, KENSUKE SHIRAISHI, SHINJI FURUYA, YOSHIHIKO KAWAGUCHI, HIROMICHI KAWAIDA and DAISUKE ICHIKAWA

Anticancer Research March 2026, 46 (3) 1719-1732; DOI: https://doi.org/10.21873/anticanres.18066

Case Reports

You have access
HPV18-positive Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Treated With Immunotherapy: A Case Report
SAKIKO MASUMOTO, MASAAKI TANAKA, KENTA YAMAMOTO, YOSHIAKI HORI, JUN KATO, TOSHIE HARA, YASUHARU KAIZAKI, TOSHIYUKI SASAGAWA, ATSUSHI YAMADA, MANABU MUTO, TORU MUKOHARA and YAYOI ANDO

Anticancer Research March 2026, 46 (3) 1733-1739; DOI: https://doi.org/10.21873/anticanres.18067
You have access
Intraoperative Indocyanine Green Imaging for Blood Flow Assessment in Very Small Remnant Stomach: A Case Report
HIROYUKI INOUE, TAKESHI KUBOTA, TOSHIYUKI KOSUGA, KEIJI NISHIBEPPU, KAZUYA TAKABATAKE, KENTO KURASHIMA, HIDEMASA KUBO, JUN KIUCHI, TAISUKE IMAMURA, KENJI NANISHI, HIROKI SHIMIZU, TOMOHIRO ARITA, YUSUKE YAMAMOTO, HIROTAKA KONISHI, RYO MORIMURA, HITOSHI FUJIWARA and ATSUSHI SHIOZAKI

Anticancer Research March 2026, 46 (3) 1741-1746; DOI: https://doi.org/10.21873/anticanres.18068
You have access
Severe Esophageal Ulceration With Enfortumab Vedotin Plus Pembrolizumab Therapy in Urothelial Carcinoma: A Case Report
HIROKI BAMBA, SATOSHI YAMAMOTO, KEITA HIGA, KOICHIRO KUROKAWA, SANJI KANAOKA and KAZUYOSHI NAKAMURA

Anticancer Research March 2026, 46 (3) 1747-1753; DOI: https://doi.org/10.21873/anticanres.18069

Corrigenda

Open Access
Corrigenda
Anticancer Research March 2026, 46 (3) 1755; DOI: https://doi.org/10.21873/anticanres.18070

Main menu

User menu

Search

Table of Contents

Review

Experimental Studies

Clinical Studies

Case Reports

Corrigenda

In this issue

Issue highlights

Jump to